165 related articles for article (PubMed ID: 16420546)
1. Temporal trends in the prescription of vitamin K antagonists in patients with atrial fibrillation.
Friberg J; Gislason GH; Gadsbøll N; Rasmussen JN; Rasmussen S; Abildstrøm SZ; Køber L; Madsen M; Torp-Pedersen C
J Intern Med; 2006 Feb; 259(2):173-8. PubMed ID: 16420546
[TBL] [Abstract][Full Text] [Related]
2. Rationale and design of AVERROES: apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment.
Eikelboom JW; O'Donnell M; Yusuf S; Diaz R; Flaker G; Hart R; Hohnloser S; Joyner C; Lawrence J; Pais P; Pogue J; Synhorst D; Connolly SJ
Am Heart J; 2010 Mar; 159(3):348-353.e1. PubMed ID: 20211294
[TBL] [Abstract][Full Text] [Related]
3. Vitamin K antagonists in patients with nonvalvular atrial fibrillation: appropriateness and quality of treatment in an Italian cohort.
Pereira de Sousa L; Burba I; Ruperto C; Lattuada L; Barbone F; Di Chiara A
J Cardiovasc Med (Hagerstown); 2013 Jul; 14(7):534-40. PubMed ID: 23328227
[TBL] [Abstract][Full Text] [Related]
4. Decision making for oral anticoagulants in atrial fibrillation: the ATA-AF study.
Gussoni G; Di Pasquale G; Vescovo G; Gulizia M; Mathieu G; Scherillo M; Panuccio D; Lucci D; Nozzoli C; Fabbri G; Colombo F; Riva L; Baldo CI; Maggioni AP; Mazzone A;
Eur J Intern Med; 2013 Jun; 24(4):324-32. PubMed ID: 23684591
[TBL] [Abstract][Full Text] [Related]
5. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
[TBL] [Abstract][Full Text] [Related]
6. Clinical consequences of hospital variation in use of oral anticoagulant therapy after first-time admission for atrial fibrillation.
Hansen ML; Gadsbøll N; Rasmussen S; Gislason GH; Folke F; Andersen SS; Schramm TK; Sørensen R; Fosbøl EL; Abildstrøm SZ; Madsen M; Poulsen HE; Køber L; Torp-Pedersen C
J Intern Med; 2009 Mar; 265(3):335-44. PubMed ID: 19141096
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of anticoagulation for stroke prevention and risk stratification in atrial fibrillation: translating trials into clinical practice.
Go AS
Am J Manag Care; 2004 Apr; 10(3 Suppl):S58-65. PubMed ID: 15152747
[TBL] [Abstract][Full Text] [Related]
8. Influence of age on the prescription of vitamin K antagonists in outpatients with permanent atrial fibrillation in France.
; Leizorovicz A; Cohen A; Guenoun M; Mismetti P; Weisslinger N
Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):32-8. PubMed ID: 17063535
[TBL] [Abstract][Full Text] [Related]
9. New pharmacotherapy for stroke prevention in atrial fibrillation: update 2010.
Armaganijan L; Eikelboom J; Healey JS; Morillo CA
Adv Ther; 2009 Dec; 26(12):1058-71. PubMed ID: 20127214
[TBL] [Abstract][Full Text] [Related]
10. [Decisional algorithm to prescribe vitamin K antagonist in geriatric patients with atrial fibrillation].
Sibai MS; Bellarbre F; Ghazali N; Bureau ML; Priner M; Ingrand P; Paccalin M
Geriatr Psychol Neuropsychiatr Vieil; 2014 Mar; 12(1):20-4. PubMed ID: 24647235
[TBL] [Abstract][Full Text] [Related]
11. Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a 'real world' nationwide cohort study.
Olesen JB; Lip GY; Lindhardsen J; Lane DA; Ahlehoff O; Hansen ML; Raunsø J; Tolstrup JS; Hansen PR; Gislason GH; Torp-Pedersen C
Thromb Haemost; 2011 Oct; 106(4):739-49. PubMed ID: 21789337
[TBL] [Abstract][Full Text] [Related]
12. Bleeding risk in very old patients on vitamin K antagonist treatment: results of a prospective collaborative study on elderly patients followed by Italian Centres for Anticoagulation.
Poli D; Antonucci E; Testa S; Tosetto A; Ageno W; Palareti G;
Circulation; 2011 Aug; 124(7):824-9. PubMed ID: 21810658
[TBL] [Abstract][Full Text] [Related]
13. Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation--a nationwide descriptive study in Taiwan.
Lin LJ; Cheng MH; Lee CH; Wung DC; Cheng CL; Kao Yang YH
Clin Ther; 2008 Sep; 30(9):1726-36. PubMed ID: 18840379
[TBL] [Abstract][Full Text] [Related]
14. [Effectiveness of anticoagulation with vitamin K antagonists in acute stroke patients with atrial fibrillation--Hungarian results].
Sas A; Csontos K; Lovász R; Valikovics A
Ideggyogy Sz; 2015 Jan; 68(1-2):47-51. PubMed ID: 25842916
[TBL] [Abstract][Full Text] [Related]
15. Long-term vitamin K antagonists treatment patterns of Non-Valvular Atrial Fibrillation (NVAF): a population-based cohort study.
Renoux C; Coulombe J; Suissa S
BMC Cardiovasc Disord; 2016 May; 16():84. PubMed ID: 27160254
[TBL] [Abstract][Full Text] [Related]
16. Stroke event rates in anticoagulated patients with paroxysmal atrial fibrillation.
Lip GY; Frison L; Grind M;
J Intern Med; 2008 Jul; 264(1):50-61. PubMed ID: 18266660
[TBL] [Abstract][Full Text] [Related]
17. New oral anticoagulants for the prevention of thromboembolic complications in atrial fibrillation: a single centre experience.
Gorczyca-Michta I; Wożakowska-Kapłon B
Kardiol Pol; 2015; 73(2):85-93. PubMed ID: 25179482
[TBL] [Abstract][Full Text] [Related]
18. Risk factors of vitamin K antagonist overcoagulation. A case-control study in unselected patients referred to an emergency department.
Cadiou G; Varin R; Levesque H; Grassi V; Benichou J; Tiret I; Dieu B; Lecam-Duchez V; Borg JY; Muller JM; Benhamou Y; Marie I
Thromb Haemost; 2008 Oct; 100(4):685-92. PubMed ID: 18841293
[TBL] [Abstract][Full Text] [Related]
19. [Frequency of use of oral vitamin K antagonists in patients with atrial fibrillation and cognitive function disturbances].
Gorzelak P; Zyzak S; Krewko Ł; Mozdzan M; Broncel M
Pol Merkur Lekarski; 2014 May; 36(215):302-6. PubMed ID: 24964505
[TBL] [Abstract][Full Text] [Related]
20. Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation.
Gallego P; Roldan V; Marín F; Romera M; Valdés M; Vicente V; Lip GY
Thromb Haemost; 2013 Dec; 110(6):1189-98. PubMed ID: 24096615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
